IBDEI1A7 ; ; 20-MAY-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,22993,1,4,0)
 ;;=4^145.5
 ;;^UTILITY(U,$J,358.3,22993,2)
 ;;=^267024
 ;;^UTILITY(U,$J,358.3,22994,0)
 ;;=210.0^^135^1389^13
 ;;^UTILITY(U,$J,358.3,22994,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22994,1,3,0)
 ;;=3^BEN NEO LIP
 ;;^UTILITY(U,$J,358.3,22994,1,4,0)
 ;;=4^210.0
 ;;^UTILITY(U,$J,358.3,22994,2)
 ;;=^267578
 ;;^UTILITY(U,$J,358.3,22995,0)
 ;;=701.9^^135^1389^132
 ;;^UTILITY(U,$J,358.3,22995,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22995,1,3,0)
 ;;=3^SKIN HYPERTRO/ATROPH NOS
 ;;^UTILITY(U,$J,358.3,22995,1,4,0)
 ;;=4^701.9
 ;;^UTILITY(U,$J,358.3,22995,2)
 ;;=^123929
 ;;^UTILITY(U,$J,358.3,22996,0)
 ;;=756.83^^135^1389^43
 ;;^UTILITY(U,$J,358.3,22996,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22996,1,3,0)
 ;;=3^EHLERS-DANLOS SYNDROME
 ;;^UTILITY(U,$J,358.3,22996,1,4,0)
 ;;=4^756.83
 ;;^UTILITY(U,$J,358.3,22996,2)
 ;;=^38754
 ;;^UTILITY(U,$J,358.3,22997,0)
 ;;=V50.1^^135^1389^117
 ;;^UTILITY(U,$J,358.3,22997,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22997,1,3,0)
 ;;=3^PLASTIC SURGERY NEC
 ;;^UTILITY(U,$J,358.3,22997,1,4,0)
 ;;=4^V50.1
 ;;^UTILITY(U,$J,358.3,22997,2)
 ;;=^87802
 ;;^UTILITY(U,$J,358.3,22998,0)
 ;;=709.2^^135^1389^124
 ;;^UTILITY(U,$J,358.3,22998,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22998,1,3,0)
 ;;=3^SCAR FIBROSIS OF SKIN
 ;;^UTILITY(U,$J,358.3,22998,1,4,0)
 ;;=4^709.2
 ;;^UTILITY(U,$J,358.3,22998,2)
 ;;=^108131
 ;;^UTILITY(U,$J,358.3,22999,0)
 ;;=216.9^^135^1389^16
 ;;^UTILITY(U,$J,358.3,22999,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22999,1,3,0)
 ;;=3^BEN NEO SKIN NOS
 ;;^UTILITY(U,$J,358.3,22999,1,4,0)
 ;;=4^216.9
 ;;^UTILITY(U,$J,358.3,22999,2)
 ;;=^13314
 ;;^UTILITY(U,$J,358.3,23000,0)
 ;;=528.5^^135^1389^71
 ;;^UTILITY(U,$J,358.3,23000,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23000,1,3,0)
 ;;=3^LIP DISEASE
 ;;^UTILITY(U,$J,358.3,23000,1,4,0)
 ;;=4^528.5
 ;;^UTILITY(U,$J,358.3,23000,2)
 ;;=^70993
 ;;^UTILITY(U,$J,358.3,23001,0)
 ;;=709.9^^135^1389^130
 ;;^UTILITY(U,$J,358.3,23001,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23001,1,3,0)
 ;;=3^SKIN DISORDER NOS
 ;;^UTILITY(U,$J,358.3,23001,1,4,0)
 ;;=4^709.9
 ;;^UTILITY(U,$J,358.3,23001,2)
 ;;=^111083
 ;;^UTILITY(U,$J,358.3,23002,0)
 ;;=140.9^^135^1389^76
 ;;^UTILITY(U,$J,358.3,23002,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23002,1,3,0)
 ;;=3^MAL NEO LIP/VERMIL NOS
 ;;^UTILITY(U,$J,358.3,23002,1,4,0)
 ;;=4^140.9
 ;;^UTILITY(U,$J,358.3,23002,2)
 ;;=^266994
 ;;^UTILITY(U,$J,358.3,23003,0)
 ;;=903.5^^135^1389^60
 ;;^UTILITY(U,$J,358.3,23003,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23003,1,3,0)
 ;;=3^INJURY FINGER VESSELS
 ;;^UTILITY(U,$J,358.3,23003,1,4,0)
 ;;=4^903.5
 ;;^UTILITY(U,$J,358.3,23003,2)
 ;;=^275191
 ;;^UTILITY(U,$J,358.3,23004,0)
 ;;=904.8^^135^1389^62
 ;;^UTILITY(U,$J,358.3,23004,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23004,1,3,0)
 ;;=3^INJURY LEG VESSEL NOS
 ;;^UTILITY(U,$J,358.3,23004,1,4,0)
 ;;=4^904.8
 ;;^UTILITY(U,$J,358.3,23004,2)
 ;;=^275211
 ;;^UTILITY(U,$J,358.3,23005,0)
 ;;=903.9^^135^1389^57
 ;;^UTILITY(U,$J,358.3,23005,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23005,1,3,0)
 ;;=3^INJURY ARM VESSEL NOS
 ;;^UTILITY(U,$J,358.3,23005,1,4,0)
 ;;=4^903.9
 ;;^UTILITY(U,$J,358.3,23005,2)
 ;;=^275193
 ;;^UTILITY(U,$J,358.3,23006,0)
 ;;=955.9^^135^1389^56
 ;;^UTILITY(U,$J,358.3,23006,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23006,1,3,0)
 ;;=3^INJ NERVE SHLDR/ARM NOS
 ;;^UTILITY(U,$J,358.3,23006,1,4,0)
 ;;=4^955.9
 ;;^UTILITY(U,$J,358.3,23006,2)
 ;;=^275961
 ;;^UTILITY(U,$J,358.3,23007,0)
 ;;=955.6^^135^1389^58
 ;;^UTILITY(U,$J,358.3,23007,1,0)
 ;;=^358.31IA^4^2
